Anbio Biotechnology (NNNN) Receivables - Net (2023 - 2025)

Historic Receivables - Net for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $3716.4 billion.

  • Anbio Biotechnology's Receivables - Net changed N/A to $3716.4 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $3716.4 billion, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 4351.11% down from last year.
  • Per Anbio Biotechnology's latest filing, its Receivables - Net stood at $3716.4 billion for Q2 2025.
  • Over the past 5 years, Anbio Biotechnology's Receivables - Net peaked at $3716.4 billion during Q2 2025, and registered a low of $1.9 million during Q4 2023.
  • Its 3-year average for Receivables - Net is $1593.7 billion, with a median of $1064.8 billion in 2024.
  • Over the last 5 years, Anbio Biotechnology's Receivables - Net had its largest YoY gain of 5648884406.25% in 2024, and its largest YoY loss of 5648884406.25% in 2024.
  • Over the past 3 years, Anbio Biotechnology's Receivables - Net (Quarter) stood at $1.9 million in 2023, then soared by 56488844.06% to $1064.8 billion in 2024, then skyrocketed by 249.02% to $3716.4 billion in 2025.
  • Its Receivables - Net was $3716.4 billion in Q2 2025, compared to $1064.8 billion in Q4 2024 and $1.9 million in Q4 2023.